Gossamer Bio Inc at Barclays Global Healthcare Conference Transcript
Okay. Good afternoon, and welcome to day 2 of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. I am pleased to welcome Gossamer Bio to the stage. Joining us from the company is Bryan Giraudo, CFO and COO; as well as Rob Roscigno, VP of Clinical Development. Guys, thank you very much for joining us today.
Great to be here. And as always, thanks for the invitation.
Bryan, I don't know if you want to make some opening comments, or we can just kind of jump into Q&A.
I think real quickly -- I think it's a very exciting time for Gossamer, our friends at Merck's, data with sotatercept. It really is heralding a new era in the treatment of PAH. And we are, one, very
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
